Different strengths – different ISV? [Power / Sample Size]

posted by mittyri  – Russia, 2014-12-21 19:04 (4195 d 22:39 ago) – Posting: # 14127
Views: 12,015

Dear All,

Are there any "rules of thumb" about the ISV prediction for a study with a new strength?
For exapmle, the formulation 50mg is registered and we're going to conduct the study with the formulation 100 mg.
The drug has linear PK to 120 mg according to the literature.
Could we plan our study with ISV derived from the previous data? Is it safe enough?
Thanks in advance!

Kind regards,
Mittyri

Complete thread:

UA Flag
Activity
 Admin contact
23,654 posts in 4,992 threads, 1,571 registered users;
144 visitors (0 registered, 144 guests [including 21 identified bots]).
Forum time: 18:44 CEST (Europe/Vienna)

Scientists often have a naïve faith that
if only they could discover enough facts about a problem,
these facts would somehow arrange themselves
in a compelling and true solution.    Theodosius Dobzhansky

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5